您使用提示模式 关闭

WDNA - WisdomTree BioRevolution Fund (USD) (US97717Y6187)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
US97717Y6187
WDNA ISIN
交易所交易基金 (ETF)
基金类型
WisdomTree
提供商
19,63 USD
每股资产净值 | 2026-07-24
2021-06-03
成立日期
1 每年的次数
股息的支付
CIOJLS
CFI
WDNA
代码
Formed
Status
Equity
投资项目
Biotech
部门
USA
地区分布
WisdomTree BioRevolution Index
基准
0.45 %
总成本比率
2,55 百万 USD
基金资产总量 | 2026-07-24
2,55 百万 USD
股票类资产 | 2026-07-24
UCITS

收益率 在 2026-07-24, Cboe BZX Exchange

  • YTD
    0,79 %
  • 1M
    -8,27 %
  • 3M
    -5,5 %
  • 6M
    7,76 %
  • 1Y
    43,78 %
  • 3Y
    5,21 %
  • 5Y
    -
  • 10Y
    -
按交换价格计算,包括收入支付

最新数据在
添加比较项目

报价 (WDNA)

探索最全面的数据库

1 000 000

债券

100 000

股票

175 910

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件

价格动态的变化

Fund profile

The WisdomTree BioRevolution Fund seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index.

WDNA profile

The WisdomTree BioRevolution Fund (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The WisdomTree fund’s base currency is USD and the share class was registered 03.06.2021 with unique ISIN - US97717Y6187. Main exchange is Cboe BZX Exchange and ticker symbol is WDNA. The total expense ratio is 0.45%. The WisdomTree BioRevolution Fund (USD) pays dividends 1 time(s) per year.

结构 WDNA 在 2026-05-14

证券
Eli Lilly & Co 3,98%
Twist Bioscience Corp 3,56%
Moderna Inc 3,44%
Johnson & Johnson 3,14%
United Therapeutics Corp 3,03%
Immunome Inc 2,73%
Darling Ingredients Inc 2,59%
Stoke Therapeutics Inc 2,33%
Corteva Inc 2,28%
Beam Therapeutics Inc 2,09%
Tempus Ai Inc 2,08%
ASTRAZENECA PLC 2,07%
Isis Pharmaceuticals Inc 2,06%
Bunge Global Sa 2,02%
Natera Inc 1,96%
Krystal Biotech Inc 1,94%
Crispr Therapeutics Ag 1,9%
Gilead Sciences Inc 1,84%
Structure Therapeutics Inc 1,83%
Roivant Sciences Ltd 1,68%
Arrowhead Pharmaceuticals Inc 1,68%
Pfizer Inc 1,67%
Amgen Inc 1,66%
Thermo Fisher Scientific Inc 1,58%
Revolution Medicines Inc 1,56%
Novozymes A/S 1,49%
Novartis AG 1,47%
Bayer AG 1,44%
Agios Pharmaceuticals Inc 1,41%
Vertex Pharmaceuticals Inc 1,41%
Catalyst Pharmaceuticals Inc 1,24%
10X Genomics Inc-Class A 1,18%
Exelixis Inc 1,14%
Veracyte Inc 1,13%
Verbio AG 1,1%
Cullinan Therapeutics Inc 1,07%
Protagonist Therapeutics Inc 1,03%
Cg Oncology Inc 1,03%
Biontech Se-ADR 1,01%
Allogene Therapeutics Inc 0,98%
Celldex Therapeutics Inc 0,98%
Editas Medicine Inc 0,98%
Biohaven Ltd 0,97%
Argenx Se - Adr 0,96%
Dyne Therapeutics Inc 0,96%
ABSCI Corp 0,95%
Viking Therapeutics Inc 0,88%
Uniqure NV 0,86%
Biogen Idec Inc 0,85%
FMC Corp 0,8%
Iovance Biotherapeutics Inc 0,76%
Danaher Corp 0,75%
Arcturus Therapeutics Hlgs 0,74%
Insmed Inc 0,73%
Green Plains Inc 0,73%
Merck & Co Inc/NJ 0,72%
Regeneron Pharmaceuticals Inc 0,71%
Sana Biotechnology Inc 0,7%
Halozyme Therapeutics Inc 0,67%
Syensqo Sa 0,64%
Repligen Corp 0,64%
Regenxbio Inc 0,56%
Ultragenyx Pharmaceutical Inc 0,54%
Nufarm Ltd/Australia 0,53%
Bridgebio Pharma Inc 0,52%
Illumina Inc 0,51%
Intellia Therapeutics Inc 0,48%
Genmab A/S -Sp ADR 0,48%
BioMarin Pharmaceutical Inc 0,47%
Oxford Nanopore Technologies 0,47%
Genus Plc 0,44%
Zoetis Inc 0,44%
Geron Corp 0,42%
Tyson Foods Inc 0,4%
Techne Corp 0,36%
Rocket Pharmaceuticals Inc 0,34%
Sarepta Therapeutics Inc 0,34%
Alnylam Pharmaceuticals Inc 0,33%
QIAGEN N.V. 0,25%
Pacific Biosciences Of Calif 0,22%
US DOLLAR 0,08%
DREYFUS TRSY OBLIG CASH MGMT CL INS 0,04%
EURO 0%
AUSTRALIAN DOLLAR 0%
SWISS FRANC 0%
GREAT BRITISH POUND 0%
DANISH KRONE 0%
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权